TABLE 5.
Treatment-emergent adverse events (>10% Mipomersen)
| Event | Placebo (n = 11) | Mipomersen (n = 10) |
|---|---|---|
| Injection site reaction | 8 (73) | 10 (100) |
| Influenza-like illness | 2 (18) | 7 (70) |
| Influenza | 1 (9) | 3 (30) |
| Nasopharyngitis | 4 (36) | 3 (30) |
| Headache | 6 (55) | 3 (30) |
| Fatigue | 5 (46) | 2 (20) |
| Myalgia | 1 (9) | 2 (20) |
| Back pain | 0 (0) | 2 (20) |
| Upper abdominal pain | 0 (0) | 2 (20) |
| Nausea | 0 (0) | 2 (20) |
| Cough | 0 (0) | 2 (20) |
The numbers in parentheses are percentages.